Angiogenesis is a double-edged sword; it is a mechanism that defines the boundary
between health and disease. In spite of its central role in physiological homeostasis, it …

Compared with traditional therapies, targeted therapy has merits in selectivity, efficacy, and
tolerability. Small molecule inhibitors are one of the primary targeted therapies for cancer …

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy derived from
parafollicular cells (C cells) of the thyroid. Here we presented a comprehensive multi-omics …

If we are to beat cancer, early detection and diagnosis are arguably the most effective
means we have at our disposal. Progress during the past 40 years has transformed the …

PURPOSE Approved systemic therapies for advanced gastroenteropancreatic
neuroendocrine tumors (GEP-NETs) have shown limited capacity to reduce tumor burden …

Introduction Neuroendocrine neoplasms (NEN) are heterogeneous malignancies that can
arise at almost any anatomical site and are classified as biologically distinct well …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms
(NENs), the emerging results of new clinical trials, and the new guidelines issued by medical …

Since its approval in 2018 by the US Food and Drug Administration, peptide receptor
radionuclide therapy (PRRT) has become a mainstay in the treatment of neuroendocrine …

Neuroendocrine neoplasms (NENs), which are characterized by neuroendocrine
differentiation, can arise in various organs. NENs have been divided into well-differentiated …